Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab

The human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, panitumumab, represents a significant advance in the treatment of colorectal cancer. The strategy to target this receptor is based on sound cancer biology demonstrating its essential role in colorectal carcinogenesis. Panitu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, George P, Grothey, Axel
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721355/
https://www.ncbi.nlm.nih.gov/pubmed/19707356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721355/
https://www.ncbi.nlm.nih.gov/pubmed/19707356

Ejemplares similares